Role of Circular <scp>RNA MMP9</scp> in Glioblastoma Progression: From Interaction With <scp>hnRNPC</scp> and <scp>hnRNPA1</scp> to Affecting the Expression of <scp>BIRC5</scp> by Sequestering <scp>miR</scp>‐149
Glioblastoma multiforme (GBM) presents a significant challenge in neuro-oncology due to its aggressive behavior and self-renewal capacity. Circular RNAs (circRNAs), a subset of non-coding RNAs (ncRNAs) generated through mRNA back-splicing, are gaining attention as potential targets for GBM research. In our study, we sought to explore the functional role of circMMP9 (circular form of matrix metalloproteinase-9) as a promising therapeutic target for GBM through bioinformatic predictions and human data analysis. Our results suggest that circMMP9 functions as a sponge for miR-149 and miR-542, both upregulated in GBM based on microarray data. Kaplan-Meier analysis indicated that reduced levels of miR-149 and miR-542 correlate with worse survival outcomes in GBM, suggesting their role as tumor suppressors. Importantly, miR-149 has been demonstrated to inhibit the expression of BIRC5 (baculoviral inhibitor of apoptosis repeat-containing 5 or survivin), a significant promoter of proliferation in GBM. BIRC5 is not only upregulated in GBM but also in various other cancers, including neuroblastoma and other brain cancers. Our protein-protein interaction analysis highlights the significance of BIRC5 as a central hub gene in GBM. CircMMP9 seems to influence this complex relationship by suppressing miR-149 and miR-542, despite their increased expression in GBM. Additionally, we found that circMMP9 directly interacts with heterogeneous nuclear ribonucleoproteins C and A1 (hnRNPC and A1), although not within their protein-binding domains. This suggests that hnRNPC/A1 may play a role in transporting circMMP9. Moreover, RNA-seq data from GBM patient samples confirmed the increased expression of BIRC5, PIK3CB, and hnRNPC/A1, further emphasizing the potential therapeutic significance of circMMP9 in GBM. In this study, we propose for the first time a new epigenetic regulatory role for circMMP9, highlighting a novel aspect of its oncogenic function. circMMP9 may regulate BIRC5 expression in GBM by sponging miR-149 and miR-542. BIRC5, in turn, suppresses apoptosis and enhances proliferation in GBM. Nonetheless, more extensive studies are advised to delve deeper into the roles of circMMP9, especially in the context of glioma.
Authors
- Bahram Bibak
- Elaheh Mozaffari
- Nima Sanadgol (ORCID: https://orcid.org/0000-0002-4509-5336)
- Javad Amini (ORCID: https://orcid.org/0000-0002-5158-2560)
- Nikta Zafarjafarzadeh (ORCID: https://orcid.org/0000-0002-5020-797X)
- Sara Ghahramanlu
- Omid Mohammadalizadeh
Institutions
- University of Tehran (IR)
- Islamic Azad University Medical Branch of Tehran (IR)
- Biotechnology Research Center (IR)
- Universitätsklinikum Aachen (DE)
- Islamic Azad University of Shahrekord (IR)
- North Khorasan University of Medical Sciences (IR)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Journal of Molecular Recognition
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1002/jmr.3109
- Citations
- 5
- Primary Topic
- Circular RNAs in diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Alexander von Humboldt-Stiftung